rheumatoid arthritis
Scipher Medicine, Roivant Partner on Rheumatology Drug Discovery
Roivant will integrate data derived from the development and commercialization of Scipher's PrismRA molecular test to inform its drug development pipeline.
Scipher Medicine, Omny Health Partner to Integrate Test Data Into EMR Network
The two firms are hopeful that integrating their respective transcriptomic and clinical datasets will help in the development of new targeted therapies.
RheumaGen Launches With $15M to Develop Cell, Gene Therapies for Autoimmune Diseases
The biotech wants to create one-time, potentially curative treatments for rheumatoid arthritis and other autoimmune diseases by editing the HLA gene.
Australia's Colonial Foundation Commits A$21M for Inflammatory Disease Dx Research Center
The new center will use spatial omics technology and be led by the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (WEHI).
Metabolon, SERA Partner on Research Into Metabolomic Biomarkers for Rheumatoid Arthritis
The project will combine Metabolon's metabolomics platform with SERA's patient samples to study molecular mechanisms of RA development and progression.